0.8222 USD
-0.03 (-3.89%)
0.8404 USD
+0.02 (+2.21%)
NOTV gets a fundamental rating of 2 out of 10. The analysis compared the fundamentals against 58 industry peers in the Life Sciences Tools & Services industry. NOTV has a bad profitability rating. Also its financial health evaluation is rather negative. While showing a medium growth rate, NOTV is valued expensive at the moment.
1. Profitability
1.1 Basic Checks
In the past year NOTV has reported negative net income.
NOTV had a negative operating cash flow in the past year.
In the past 5 years NOTV reported 4 times negative net income.
In multiple years NOTV reported negative operating cash flow during the last 5 years.
1.2 Ratios
The Return On Assets of NOTV (-10.41%) is comparable to the rest of the industry.
The Return On Equity of NOTV (-54.99%) is worse than 74.14% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.41% | ||
| ROE | -54.99% | ||
| ROIC | N/A |
ROA(3y)-20.38%
ROA(5y)-13.08%
ROE(3y)-65.39%
ROE(5y)-49.53%
ROIC(3y)N/A
ROIC(5y)N/A
1.3 Margins
With a Gross Margin value of 23.33%, NOTV is not doing good in the industry: 79.31% of the companies in the same industry are doing better.
In the last couple of years the Gross Margin of NOTV has declined.
NOTV does not have Profit Margin and Operating Margin available, so we won't be analyzing them here.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 23.33% |
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.4%
GM growth 5Y-6.74%
2. Health
2.1 Basic Checks
NOTV does not have a ROIC to compare to the WACC, probably because it is not profitable.
Compared to 1 year ago, NOTV has more shares outstanding
The number of shares outstanding for NOTV has been increased compared to 5 years ago.
Compared to 1 year ago, NOTV has a worse debt to assets ratio.
2.2 Solvency
Based on the Altman-Z score of -0.57, we must say that NOTV is in the distress zone and has some risk of bankruptcy.
Looking at the Altman-Z score, with a value of -0.57, NOTV is doing worse than 77.59% of the companies in the same industry.
A Debt/Equity ratio of 2.73 is on the high side and indicates that NOTV has dependencies on debt financing.
NOTV has a Debt to Equity ratio of 2.73. This is amonst the worse of the industry: NOTV underperforms 87.93% of its industry peers.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.73 | ||
| Debt/FCF | N/A | ||
| Altman-Z | -0.57 |
ROIC/WACCN/A
WACC7.94%
2.3 Liquidity
NOTV has a Current Ratio of 1.29. This is a normal value and indicates that NOTV is financially healthy and should not expect problems in meeting its short term obligations.
Looking at the Current ratio, with a value of 1.29, NOTV is doing worse than 84.48% of the companies in the same industry.
A Quick Ratio of 0.96 indicates that NOTV may have some problems paying its short term obligations.
With a Quick ratio value of 0.96, NOTV is not doing good in the industry: 84.48% of the companies in the same industry are doing better.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Current Ratio | 1.29 | ||
| Quick Ratio | 0.96 |
3. Growth
3.1 Past
The Earnings Per Share has grown by an impressive 29.69% over the past year.
Looking at the last year, NOTV shows a small growth in Revenue. The Revenue has grown by 0.85% in the last year.
The Revenue has been growing by 62.28% on average over the past years. This is a very strong growth!
EPS 1Y (TTM)29.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49%
Revenue 1Y (TTM)0.85%
Revenue growth 3Y76.27%
Revenue growth 5Y62.28%
Sales Q2Q%23.54%
3.2 Future
Based on estimates for the next years, NOTV will show a very strong growth in Earnings Per Share. The EPS will grow by 24.97% on average per year.
NOTV is expected to show quite a strong growth in Revenue. In the coming years, the Revenue will grow by 14.23% yearly.
EPS Next Y43.04%
EPS Next 2Y24.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue Next Year6.5%
Revenue Next 2Y5.82%
Revenue Next 3Y17.67%
Revenue Next 5Y14.23%
3.3 Evolution
The estimated forward Revenue growth is still strong, although it is decreasing when compared to the stronger growth in the past years.
4. Valuation
4.1 Price/Earnings Ratio
NOTV reported negative earnings for the last year, which makes the Price/Earnings Ratio negative.
Also next year NOTV is expected to report negative earnings again, which makes the also the Forward Price/Earnings Ratio negative.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A |
4.2 Price Multiples
Based on the Enterprise Value to EBITDA ratio, NOTV is valued a bit cheaper than 63.79% of the companies in the same industry.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| P/FCF | N/A | ||
| EV/EBITDA | 26.97 |
4.3 Compensation for Growth
NOTV's earnings are expected to grow with 24.97% in the coming years. This may justify a more expensive valuation.
PEG (NY)N/A
PEG (5Y)N/A
EPS Next 2Y24.97%
EPS Next 3YN/A
5. Dividend
5.1 Amount
No dividends for NOTV!.
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
0.8222
-0.03 (-3.89%)
Chartmill FA Rating
GICS SectorHealth Care
GICS IndustryGroupPharmaceuticals, Biotechnology & Life Sciences
GICS IndustryLife Sciences Tools & Services
Earnings (Last)
Earnings (Next)
Inst Owners25.37%
Inst Owner Change-3.16%
Ins Owners9.67%
Ins Owner Change0%
Market Cap28.24M
Revenue(TTM)505.30M
Net Income(TTM)-79.07M
Analysts80
Price Target5.61 (582.32%)
Short Float %6.59%
Short Ratio3.21
Dividend
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Dividend Yield | N/A |
Yearly DividendN/A
Dividend Growth(5Y)N/A
DPN/A
Div Incr Years0
Div Non Decr Years0
Ex-DateN/A
Surprises & Revisions
EPS beat(2)2
Avg EPS beat(2)17.49%
Min EPS beat(2)2.91%
Max EPS beat(2)32.07%
EPS beat(4)3
Avg EPS beat(4)12.77%
Min EPS beat(4)-5.26%
Max EPS beat(4)32.07%
EPS beat(8)4
Avg EPS beat(8)-23.22%
EPS beat(12)7
Avg EPS beat(12)-12.32%
EPS beat(16)10
Avg EPS beat(16)95.16%
Revenue beat(2)1
Avg Revenue beat(2)-0.42%
Min Revenue beat(2)-1.67%
Max Revenue beat(2)0.84%
Revenue beat(4)2
Avg Revenue beat(4)1.24%
Min Revenue beat(4)-3.54%
Max Revenue beat(4)9.34%
Revenue beat(8)2
Avg Revenue beat(8)-2.76%
Revenue beat(12)5
Avg Revenue beat(12)-0.89%
Revenue beat(16)9
Avg Revenue beat(16)2.78%
PT rev (1m)0%
PT rev (3m)0%
EPS NQ rev (1m)0%
EPS NQ rev (3m)-6.98%
EPS NY rev (1m)0%
EPS NY rev (3m)0%
Revenue NQ rev (1m)0%
Revenue NQ rev (3m)0%
Revenue NY rev (1m)0%
Revenue NY rev (3m)0%
Valuation
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| PE | N/A | ||
| Fwd PE | N/A | ||
| P/S | 0.06 | ||
| P/FCF | N/A | ||
| P/OCF | N/A | ||
| P/B | 0.2 | ||
| P/tB | N/A | ||
| EV/EBITDA | 26.97 |
EPS(TTM)-2.7
EYN/A
EPS(NY)-1.84
Fwd EYN/A
FCF(TTM)-1.34
FCFYN/A
OCF(TTM)-0.79
OCFYN/A
SpS14.71
BVpS4.19
TBVpS-5.81
PEG (NY)N/A
PEG (5Y)N/A
Graham NumberN/A
Profitability
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| ROA | -10.41% | ||
| ROE | -54.99% | ||
| ROCE | N/A | ||
| ROIC | N/A | ||
| ROICexc | N/A | ||
| ROICexgc | N/A | ||
| OM | N/A | ||
| PM (TTM) | N/A | ||
| GM | 23.33% | ||
| FCFM | N/A |
ROA(3y)-20.38%
ROA(5y)-13.08%
ROE(3y)-65.39%
ROE(5y)-49.53%
ROIC(3y)N/A
ROIC(5y)N/A
ROICexc(3y)N/A
ROICexc(5y)N/A
ROICexgc(3y)N/A
ROICexgc(5y)N/A
ROCE(3y)N/A
ROCE(5y)N/A
ROICexgc growth 3YN/A
ROICexgc growth 5YN/A
ROICexc growth 3YN/A
ROICexc growth 5YN/A
OM growth 3YN/A
OM growth 5YN/A
PM growth 3YN/A
PM growth 5YN/A
GM growth 3Y-12.4%
GM growth 5Y-6.74%
F-Score4
Asset Turnover0.67
Health
| Industry Rank | Sector Rank | ||
|---|---|---|---|
| Debt/Equity | 2.73 | ||
| Debt/FCF | N/A | ||
| Debt/EBITDA | 25.13 | ||
| Cap/Depr | 33.83% | ||
| Cap/Sales | 3.75% | ||
| Interest Coverage | N/A | ||
| Cash Conversion | N/A | ||
| Profit Quality | N/A | ||
| Current Ratio | 1.29 | ||
| Quick Ratio | 0.96 | ||
| Altman-Z | -0.57 |
F-Score4
WACC7.94%
ROIC/WACCN/A
Cap/Depr(3y)54.31%
Cap/Depr(5y)102.83%
Cap/Sales(3y)5.33%
Cap/Sales(5y)8.03%
Profit Quality(3y)N/A
Profit Quality(5y)N/A
High Growth Momentum
Growth
EPS 1Y (TTM)29.69%
EPS 3YN/A
EPS 5YN/A
EPS Q2Q%49%
EPS Next Y43.04%
EPS Next 2Y24.97%
EPS Next 3YN/A
EPS Next 5YN/A
Revenue 1Y (TTM)0.85%
Revenue growth 3Y76.27%
Revenue growth 5Y62.28%
Sales Q2Q%23.54%
Revenue Next Year6.5%
Revenue Next 2Y5.82%
Revenue Next 3Y17.67%
Revenue Next 5Y14.23%
EBIT growth 1Y-40.06%
EBIT growth 3YN/A
EBIT growth 5YN/A
EBIT Next Year434.73%
EBIT Next 3YN/A
EBIT Next 5YN/A
FCF growth 1Y-144.96%
FCF growth 3YN/A
FCF growth 5YN/A
OCF growth 1Y-460.42%
OCF growth 3YN/A
OCF growth 5YN/A
INOTIV INC / NOTV FAQ
Can you provide the ChartMill fundamental rating for INOTIV INC?
ChartMill assigns a fundamental rating of 2 / 10 to NOTV.
Can you provide the valuation status for INOTIV INC?
ChartMill assigns a valuation rating of 1 / 10 to INOTIV INC (NOTV). This can be considered as Overvalued.
What is the profitability of NOTV stock?
INOTIV INC (NOTV) has a profitability rating of 1 / 10.
Can you provide the expected EPS growth for NOTV stock?
The Earnings per Share (EPS) of INOTIV INC (NOTV) is expected to grow by 43.04% in the next year.